How GMOs Are Regulated Around the World

Global GMO Regulation: A Comparative Overview

The regulation of genetically modified organisms varies dramatically around the world, reflecting different risk assessment philosophies, political pressures, trade interests, and cultural values.

The United States Approach

The US uses a product-based regulatory framework, meaning that the regulatory oversight depends on the characteristics of the product, not the process used to create it. Three agencies share responsibility:

• FDA (Food and Drug Administration): Evaluates safety for human consumption
• USDA (Department of Agriculture): Evaluates environmental safety and agricultural impacts
• EPA (Environmental Protection Agency): Regulates GMO crops with pesticidal properties (like Bt crops)

The US has approved dozens of GMO crops and takes a relatively permissive approach, with mandatory disclosure (not "labeling") required under the National Bioengineered Food Disclosure Standard since 2022.

The European Union Approach

The EU uses a process-based regulatory framework, meaning that any product created through genetic modification is subject to GMO regulations, regardless of whether the final product differs from conventionally bred varieties.

The EU requires:

• Pre-market safety assessment by EFSA
• Authorization by the European Commission
• Mandatory labeling for foods containing >0.9% GMO ingredients
• Post-market monitoring

The EU has approved very few GMO crops for cultivation (mainly MON 810 Bt maize in limited areas) but imports large quantities of GMO crops for animal feed.

Developing Countries

Many developing countries are increasingly adopting GMO crops:

• Brazil: World's second-largest GMO crop producer
• India: Bt cotton widely adopted; ongoing debates about food crops
• Bangladesh: Approved Bt brinjal (eggplant) to help small farmers
• Africa: Several countries developing GMO crops for local needs (drought-tolerant maize, disease-resistant cassava)

The Precautionary Principle Debate

A central tension in GMO regulation is the application of the precautionary principle — the idea that when scientific evidence is uncertain, regulatory action should err on the side of caution. Europe applies this principle more strictly than the US, leading to different approval timelines and requirements.

New Genomic Techniques

The emergence of CRISPR and other new genomic techniques has created regulatory uncertainty. Some countries are developing new frameworks that treat gene-edited crops differently from transgenic GMOs, recognizing that gene editing can produce changes indistinguishable from natural mutations.